Analysis of antibiotic susceptibility patterns of Helicobacter pylori isolates from Malaysia

Helicobacter

Volumn 16, Issue 1, 2011, Pages 47-51

  Ahmad, Norazah ^a   Zakaria, Wan Rasinah ^a   Mohamed, Ramelah ^b  

^a INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Amoxicillin; Antibiotic resistance; Clarithromycin resistance; Helicobacter pylori infection; Levofloxacin; Metronidazole resistance

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL TRIAL; EPSILOMETER TEST; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH BIOPSY;

ANTI-BACTERIAL AGENTS; BIOPSY; DRUG RESISTANCE, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALAYSIA; MICROBIAL SENSITIVITY TESTS; STOMACH;

HELICOBACTER PYLORI;

EID: 78751531095     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2010.00816.x     Document Type: Article

References (37)

1. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71.
2. Huang JQ, Hunt RH. Review article: Helicobacter pylori and gastric cancer - the clinicians' point of view. Aliment Pharmacol Ther 2000;14(Suppl 3):S48-54.
3. Sugiyama T, Sakaki N, Kozawa H, et al. Sensitivity of biopsy site in evaluating regression of gastric atrophy after Helicobacter pylori eradication treatment. Aliment Pharmacol Ther 2002;16(Suppl 2):S187-90.
4. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81.
5. Megraud F. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 1998;115:1278-82.
6. Megraud F. Helicobacter pylori antibiotic resistance: prevalence, importance and advances in testing. Gut 2004;53:1374-84.
7. Goh KL. Prevalence of and risk factors for Helicobacter pylori infection in a multiracial dyspeptic Malaysian undergoing endoscopy. J Gastroenterol Hepatol 1997;12:29-35.
8. Pillay KV, Htun M, Naing NN, Norsa'adah B. Helicobacter pylori infection in peptic ulcer disease: the importance of smoking and ethnicity. Southeast Asian J Trop Med Public Health 2007;38:1102-10.
9. Kim JM, Kim JS, Kim L, Jung HC, Song IS. Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. J Antimicrob Chemother 2005;56:965-7.
10. Kim JJ, Reddy R, Lee M, Kim JG, El-Zaatari FAK, Osato MS, Graham DY, Kwon DH. Analysis of metronidazole, clarithromycin & tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother 2001;47:459-61.
11. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
12. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187-94.
13. Salasawati H, Ramelah M, Jasmi A, Mazlan N, Isa R, Alfizah H, Aminuddin A. Antibiotic resistance of Helicobacter pylori: association with gastroduodenal disease in Malaysia. Med J Malaysia 2001;56(Suppl A):65.
14. Chowdhury A, Berg DE, Jeong JY, Mukhopadhyay AK, Nair GB. Metronidazole resistance in Helicobacter pylori: magnitude, mechanism and implications for India. Indian J Gastroenterol 2002;21:23-8.
15. Torres J, Camorlinga-Ponce M, Pérez-Pérez G, Madrazo-De la Garza A, Dehesa M, González-Valencia G, Muñoz O. Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico. J Clin Microbiol 2001;39:2677-80.
16. Debets-Ossenkopp YJ, Reyes G, Mulder J, aan de Stegge BM, Peters JT, Savelkoul PH, Tanca J, Pena AS, Vandenbroucke-Grauls CM. Characteristics of clinical H. pylori strains from Ecuador. J Antimicrob Chemother 2003;51:141-5.
17. John Albert M, Al-Mekhaizeem K, Neil L, Dhar R, Dhar PM, Al-Ali M, Al-Abkal HM, Haridas S. High prevalence and level of resistance to metronidazole, but lack of resistance to other antimicrobials in Helicobacter pylori, isolated from a multiracial population in Kuwait. Aliment Pharmacol Ther 2006;24:1359-66.
18. Hu CT, Wu CC, Lin CY, Cheng CC, Su SC, Tseng YH, Lin NT. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan. J Gastroenterol Hepatol 2007;22:720-3.
19. Raymond J, Kalach N, Bergeret M, Benhamou PH, Barbet JP, Gendrel D, Dupont C. Effect of metronidazole resistance on bacterial eradication of Helicobacter pylori in infected children. Antimicrob Agents Chemother 1998;42:1334-5.
20. Kalach N, Serhal L, Asmar E, et al. Helicobacter pylori primary resistant strains over 11 years in French children. Diagn Microbiol Infect Dis 2007;59:217-22.
21. Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, Delaney B. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ 2000;321:659-64.
22. Metz DC, Kroser JA. Helicobacter pylori and gastroesophageal reflux disease. Gastroenterol Clin North Am 1999;28:971-85.
23. Storskrubb T, Aro P, Ronkainen J, Wreiber K, Nyhlin H, Bolling-Sternevald E, Talley NJ, Engstrand L, Agreus L. Antimicrobial susceptibility of Helicobacter pylori strains in a random adult Swedish population. Helicobacter 2006;11:224-30.
24. Eun CS, Han DS, Park JY, Jeon YC, Hahm JS, Kim KS, Kang JO. Changing pattern of antimicrobial resistance of Helicobacter pylori in Korean patients with peptic ulcer diseases. J Gastroenterol 2003;38:436-41.
25. Yakoob J, Fan X, Hu G, Liu L, Zhang Z. Antibiotic susceptibility of Helicobacter pylori in the Chinese population. J Gastroenterol Hepatol 2001;16:981-5.
26. Bruce MG, Bruden DL, McMahon BJ, et al. Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003. Helicobacter 2006;11:581-8.
27. Raymond J, Lamarque D, Kalach N, Chaussade S, Burucoa C. High level of antimicrobial resistance in French Helicobacter pylori isolates. Helicobacter 2010;15:21-7.
28. Rimbara E, Noguchi N, Tanabe M, Kawai T, Matsumoto Y, Sasatsu M. Susceptibilities to clarithromycin, amoxicillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995-2001. Clin Microbiol Infect 2005;11:307-11.
29. Gisbert JP, de la Morena F. Systemic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther 2006;23:35-44.
30. Saad RJ, Schoenfeld P, Kim HM, Chey WD. Levofloxacin-based therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis. Am J Gastroenterol 2006;101:488-96.
31. Fujimura S, Kato S, Iinuma K, Watanabe A. In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children. J Med Microbiol 2004;53:1019-22.
32. Thyagarajan SP, Ray P, Das BK, et al. Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: multicentric study. J Gastroenterol Hepatol 2003;18:1373-8.
33. Raymond J, Nguyen B, Bergeret M, Dupont C, Kalach N. Heterogenous susceptibility to metronidazole and clarithromycin of Helicobacter pylori isolates from a single biopsy in adults is confirmed in children. Int J Antimicrob Agents 2005;26:272-8.
34. Van der Wouden EJ, de Jong A, Thijs JC, Kleibeuker JH, van Zwer AA. Subpopulations of Helicobacter pylori are responsible for discrepancies in the outcome of nitro-imidazole susceptibility testing. Antimicrob Agents Chemother 1999;43:1484-6.
35. Wong BC, Wang WH, Berg DE, Fung FM, Wong KW, Wong WM, Lai KC, Cho CH, Hui WM, Lam SK. High prevalence of mixed infections by Helicobacter pylori in Hong Kong: metronidazole sensitivity and overall genotype. Aliment Pharmacol Ther 2001;15:493-503.
36. Goodwin A, Kersulyte D, Sisson G, Veldhuyzen van Zanten SJO, Berg DE, Hoffman PS. Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase. Mol Microbiol 1998;28:383-93.
37. Dzierzanowska-Fangrat K, Rozynek E, Celinska-Cedro D, et al. Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study. Int J Antimicrob Agents 2005;26:230-4.